Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Teva’s 'Key Ingredient' For Growth: Biosimilars

Sep 13 2016

• By Jessica Merrill

laboratory

Related Content

Teva CEO Vigodman Reveals A First Glimpse At His Strategy

May 01 2014

Teva’s G-CSF Product Clears FDA, Leaving Appeal Of Biosimilar Pathway Uncertain

Sep 03 2012

Teva Embarks On New Phase With FTC Clearance Of Allergan Generics

Jul 28 2016

Related Companies

Teva Pharmaceutical Industries Ltd.

Allergan plc

Novartis AG

Pfizer Inc.

Amgen, Inc.

Celltrion, Inc.

Johnson & Johnson

Additional Topics

Biosimilars Deals Commercial Business Strategies Strategy BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window